EHEthan G. Hughes

Ethan G. Hughes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ethan G. Hughes has a total of 207 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Activity-gated exocytosis drives myelin remodeling required for adult learning

    by Mable Lam, Oleh Dehtiarov, Anna C. Geraghty, Belgin Yalçın, Lauren Duan, Manasi Iyer, Kristen H. Schuster, Michelle Monje, Ethan G. Hughes, J. Bradley Zuchero

    Myelin remodeling is emerging as a dynamic facet of plasticity in the adult brain. Learning and sensory experience induce remodeling of existing myelin sheaths through incompletely understood mechanisms, leaving its causal contribution to adaptive behaviors unclear. Here, we identify activity– dependent exocytosis in mature oligodendrocytes as a key driver of myelin remodeling. Live-cell imaging reveals that neuronal activity stimulates oligodendrocyte exocytosis. Exocytosis in mature oligodendrocytes drives myelin sheath elongation on optogenetically stimulated axons in adult mice. Disrupting exocytosis in pre-existing myelin, but not newly formed myelin, impairs motor skill acquisition, suggesting that remodeling of pre-existing myelin sheaths is required for learning. These results uncover a cellular mechanism that couples neuronal activity to myelin membrane remodeling and provide a molecular handle to interrogate the function of myelin plasticity across different circuits, behaviors, and neurological disorders.

  • Open Access

    Microglia drive demyelination via multiple sclerosis antibodies and BTK signaling

    by Lindsay A. Osso, Helena J. Barr, Michael E. Stockton, Maureen Wentling, Stephanie Karas, Rongchen Huang, Graham C. Peet, Katherine S. Given, Arlo Simmerman, Crystal R. McClain, et al.

    Microglia are the predominant immune cells in multiple sclerosis (MS) demyelinating lesions, where they phagocytose myelin, but whether they destroy myelin or merely scavenge its debris is unknown. Here, we explore whether pathogenic autoantibodies found in MS may induce the phagocytic destruction of myelin by microglia. Applying patient-derived, myelin-targeting antibodies to the mouse cortex, we developed an in vivo model of MS with focal demyelination that depended on epitope specificity and Fc gamma receptor and complement binding. Longitudinal monitoring of microglia-myelin interactions using in vivo two-photon microscopy revealed rapid microglial envelopment of intact myelin driving myelin loss, while single-cell RNA sequencing identified a demyelination-associated microglial signature. Parallel changes were observed in human MS lesions, where microglia enveloped intact myelin and similar genes were upregulated. Inhibition of Bruton’s tyrosine kinase (BTK) limited microglial transcriptional changes and prevented myelin loss following microglial envelopment. These findings directly implicate microglia in pathological myelin loss and support BTK inhibition as a therapeutic strategy to prevent demyelination by modulating microglia behavior.

  • Timing is everything: myelin and coincidence detection

    by Kimberly Gagnon, Gustavo Della Flora Nunes, Cristin G. Welle, Ethan G. Hughes


  • Open Access

    Premyelinating Oligodendrocyte Survival Governs CNS Remyelination

    by Michael E. Stockton, Maureen Wentling, Yessenia I. Mancha Corchado, Abigail Kucera, Stephanie Karas, Tania A. Seabrook, Clara Mutschler, Lindsay A. Osso, Kristen H. Schuster, Gustavo Della-Flora Nunes, et al.

    Myelinating oligodendrocytes are produced throughout life by the constitutive differentiation of oligodendrocyte precursor cells (OPCs). However, the rate of oligodendrocyte generation changes with age and after a demyelinating injury. Here, we report that variation in premyelinating oligodendrocyte (preOL) survival modulates the rate of oligodendrocyte production. PreOL survival increased to drive the regeneration of oligodendrocytes after demyelination and decreased in middle-aged mice to contribute to age-related decline in oligodendrocyte production. Furthermore, we demonstrate that treatment with a GPR17 antagonist, Myro-02, increases oligodendrocyte replacement by promoting preOL survival after demyelination. Together, our findings demonstrate that increased survival of preOLs governs the regeneration of oligodendrocytes following demyelinating injury and suggest that modulating preOL survival may be an alternative therapeutic avenue to promote oligodendrocyte regeneration.


  • Open Access

    Myelin Supports Cortical Circuit Function Underlying Skilled Movement

    by Kimberly Gagnon, Gustavo Della Flora Nunes, Dailey Nettles, Thomas Nguyen, Elise R. Carter, Andreza Lins, Ryan Williamson, Jeremie Lefebvre, Daniel Denman, Ethan G. Hughes, et al.

    Primary motor cortex (M1) is among the most heavily myelinated cortical regions and generates tightly coordinated neuronal activity patterns that drive skilled movement. Activity-dependent myelination is required for motor skill acquisition, and myelin loss in demyelinating diseases such as multiple sclerosis leads to motor impairment. Yet how myelination influences neuronal activity underlying skilled behavior remains unclear. By combining in vivo imaging of oligodendrocytes with high density Neuropixels recordings during dexterous reaching, we demonstrate that cuprizone-induced demyelination impairs movement efficiency, and alters cell-type–specific neuronal activity and synchrony in a manner that predicts motor output. Using a computational model constrained by these data, we identify inhibitory axonal propagation failures as a mechanistic link between myelin loss and altered circuit function. Partial remyelination normalizes cortical network-level metrics and reach consistency but leaves smooth movement impaired, revealing a selective vulnerability in inhibitory circuits. These findings close a critical gap between cellular models of demyelination and clinical motor impairment by demonstrating how myelin supports cortical circuit dynamics driving skilled behavior.


  • Open Access

    Author Correction: Dynamics of mature myelin

    by Lindsay A. Osso, Ethan G. Hughes

  • Open Access

    Incomplete remyelination via therapeutically enhanced oligodendrogenesis is sufficient to recover visual cortical function

    by Gustavo Della-Flora Nunes, Lindsay A. Osso, Johana A. Haynes, Lauren Conant, Michael A. Thornton, Michael E. Stockton, Katherine A. Brassell, Amanda Morris, Yessenia I. Mancha Corchado, John A. Gaynes, et al.

    Myelin loss induces neural dysfunction and contributes to the pathophysiology of neurodegenerative diseases, injury conditions, and aging. Because remyelination is often incomplete, better understanding endogenous remyelination and developing remyelination therapies that restore neural function are clinical imperatives. Here, we use in vivo two-photon microscopy and electrophysiology to study the dynamics of endogenous and therapeutic-induced cortical remyelination and functional recovery after cuprizone-mediated demyelination in mice. We focus on the visual pathway, which is uniquely positioned to provide insights into structure-function relationships during de/remyelination. We show endogenous remyelination is driven by recent oligodendrocyte loss and is highly efficacious following mild demyelination, but fails to restore the oligodendrocyte population when high rates of oligodendrocyte loss occur quickly. Testing a thyromimetic (LL-341070) compared to clemastine, we find it better enhances oligodendrocyte gain and hastens recovery of neuronal function. The therapeutic benefit of the thyromimetic is temporally restricted, and it acts exclusively following moderate to severe demyelination, eliminating the endogenous remyelination deficit. However, we find regeneration of oligodendrocytes and myelin to healthy levels is not necessary for recovery of visual neuronal function. These findings advance our understanding of remyelination and its impact on functional recovery to inform future therapeutic strategies.


  • Top Cited Papers

    Dynamics of mature myelin

    by Lindsay A. Osso, Ethan G. Hughes

    Myelin, which is produced by oligodendrocytes, insulates axons to facilitate rapid and efficient action potential propagation in the central nervous system. Traditionally viewed as a stable structure, myelin is now known to undergo dynamic modulation throughout life. This Review examines these dynamics, focusing on two key aspects: (1) the turnover of myelin, involving not only the renewal of constituents but the continuous wholesale replacement of myelin membranes; and (2) the structural remodeling of pre-existing, mature myelin, a newly discovered form of neural plasticity that can be stimulated by external factors, including neuronal activity, behavioral experience and injury. We explore the mechanisms regulating these dynamics and speculate that myelin remodeling could be driven by an asymmetry in myelin turnover or reactivation of pathways involved in myelin formation. Finally, we outline how myelin remodeling could have profound impacts on neural function, serving as an integral component of behavioral adaptation.


  • Open Access

    Paired vagus nerve stimulation drives precise remyelination and motor recovery after myelin loss

    by Rongchen Huang, Elise R. Carter, Ethan G. Hughes, Cristin G. Welle

    Summary Myelin loss in the central nervous system can cause permanent motor or cognitive deficits in patients with multiple sclerosis (MS). While current immunotherapy treatments decrease the frequency of demyelinating episodes, they do not promote myelin repair or functional recovery. Vagus nerve stimulation (VNS) is a neuromodulation therapy which enhances neuroplasticity and the recovery of motor function after stroke, but its effects on myelin repair are not known. To determine if VNS influences myelin repair, we applied VNS following a demyelinating injury and measured longitudinal myelin dynamics and functional recovery. We found that VNS promotes remyelination by increasing the generation of myelinating oligodendrocytes. Pairing VNS with a skilled reach task leads to the regeneration of myelin sheaths on previously myelinated axon segments, enhancing the restoration of the original pattern of myelination. Moreover, the magnitude of sheath pattern restoration correlates with long-term motor functional improvement. Together, these results suggest that recovery of the myelin sheath pattern is a key factor in the restoration of motor function following myelin loss and identify paired VNS as a potential remyelination therapy to treat demyelinating diseases.